AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21168198
Drug: Topotecan 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan 4.0 mg/m2/day on days 1, 8, and 15 of a 28-day cycle (regimen II)
Trial: 23490397
Drug: Single-tooth implants
RxNorm normalized name: Sus scrofa tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-tooth implants
Trial: 17348888
Drug: Intraindividual comparison
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraindividual comparison (implant vs natural tooth)
Trial: 14977817
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of gefitinib combined
Trial: 14977817
Drug: Gefitinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (250 or 500 mg daily)
Trial: 9134944
Drug: 200 mg/d
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d of vitamin E
Trial: 9134944
Drug: 60 mg/d
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/d of vitamin E
Trial: 9134944
Drug: 800 mg/d
RxNorm normalized name: RibaTab 800 mg/day Compliance Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg/d of vitamin E
Trial: 2979270
Drug: Omeprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (30 mg o.m.)
Trial: 8439641
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg b.d.)
Trial: 28846200
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline inhalation (HSI)
Trial: 23297638
Drug: Antibiotics of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics of a wide spectrum of action
Trial: 20545993
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg per day for 3 months)
Trial: 20545993
Drug: Lisinopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10 mg per day for 3 months)
Trial: 15856233
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m(2) followed by Carboplatin AUC 7
Trial: 15856233
Drug: Docetaxel 70
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 70 mg/m(2) followed by Carboplatin AUC 6
Trial: 12067917
Drug: 400 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg/kg FFR‐rFVIIa and 40 to 50 U/kg heparin
Trial: 12067917
Drug: 200 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg/kg FFR‐rFVIIa and 100 U/kg heparin
Trial: 12067917
Drug: 50 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 microg/kg FFR‐rFVIIa and 100 U/kg heparin
Trial: 1549928
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray 200 mg
Trial: 4040338
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of adenoidectomy and tympanostomy tubes
Trial: 30636639
Drug: Macintosh Laryngoscope
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macintosh Laryngoscope (ML)
Trial: 24666696
Drug: SB‐705498 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB‐705498 (600 mg)
Trial: 20453006
Drug: Functional regulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional regulator III (FR‐3) treatment
Trial: 16340712
Drug: Education regarding
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education regarding back therapy and pain management combined with three consecutive days of topical heat therapy (104 degrees F or 40 degrees C for 8 hours)
Trial: 16340712
Drug: Education regarding
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education regarding back therapy and pain management alone
Trial: 12081835
Drug: Iron supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplements (1 mg x kg(‐1) x d(‐1)) from 4 to 9 mo of age
Trial: 12081835
Drug: Placebo from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo from 4 to 6 mo and iron supplements from 6 to 9 mo
Trial: 9873848
Drug: HIV protease
RxNorm normalized name: protease
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV protease inhibitors
Trial: 8021437
Drug: Citalopram 10-30
RxNorm normalized name: citalopram 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 10-30 mg
Trial: 8021437
Drug: Citalopram 20-60
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20-60 mg
Trial: 8021437
Drug: Imipramine 50-150
RxNorm normalized name: imipramine pamoate 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 50-150 mg
Trial: 28782109
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion triggered by hb < 8 g/dl
Trial: 28782109
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion triggered by hb < 9.7 g/dl
Trial: 21572152
Drug: Febuxostat 40
RxNorm normalized name: febuxostat 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat 40 mg, 80 mg, or 120 mg daily
Trial: 21572152
Drug: Febuxostat (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (any dose)
Trial: 17925336
Drug: Vildagliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin (50 mg every day)
Trial: 8097102
Drug: ebastine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ebastine (20 mg)
Trial: 8097102
Drug: diazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (15 mg)
Trial: 3746897
Drug: Biological cause
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological cause group
Trial: 29559597
Drug: Ozonated water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonated water bath and ozonated oil topical application once a day for 4 weeks
Trial: 29559597
Drug: Naftifine hydrochloride
RxNorm normalized name: Naftifine Hydrochloride
DrugBank: Naftifine (DB00735)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naftifine hydrochloride and ketoconazole cream once a day for 4 weeks
Trial: 26927237
Drug: Weekly use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly use of ibuprofen
Trial: 18391640
Drug: Plasma vasoconstrictor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma vasoconstrictor hormones
Trial: 15798044
Drug: Treatment to
RxNorm normalized name: Lice Treatment Topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment to lower intraocular pressure
Trial: 12213354
Drug: Sarpogrelate hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate hydrochloride (5‐HT(A2) receptor antagonist)
Trial: 10626097
Drug: levodopa-benserazide dispersible
RxNorm normalized name: benserazide / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levodopa-benserazide dispersible formulation
Trial: 21541030
Drug: High-temperature meat
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-temperature meat diet with inhibitors (cruciferous vegetables, yogurt, chlorophyllin tablets)
Trial: 21541030
Drug: Inhibitor diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhibitor diet
Trial: 17474807
Drug: CP-448,187 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-448,187 (3 mg/day)
Trial: 15632984
Drug: Gestalt therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestalt therapy, Rosen Body Work, and Cranio Sacral therapy (2-day course followed by 6-10 individual sessions and a 1-day follow-up course)
Trial: 9522319
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal estrogen replacement therapy (50 micrograms 17/beta‐estradiol/day, eight patches/cycle)
Trial: 9522319
Drug: Cyclical transdermal
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclical transdermal estrogen replacement therapy (50 micrograms 17/beta‐estradiol/day, six patches/cycle, 3 weeks on, 1 week off)
Trial: 9522319
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Continuous and Cyclical)
Trial: 7957543
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ciclotropium intravenous infusion
Trial: 3108355
Drug: Sulpiride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (1 mg/kg im) + Placebo (2 ml saline iv)
Trial: 3108355
Drug: Sulpiride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (1 mg/kg im)
Trial: 3108355
Drug: Sulpiride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (1 mg/kg im) + TRH (200 micrograms iv)
Trial: 3108355
Drug: Control standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control standard insulin tolerance test (0.1 U/kg iv)
Trial: 15808245
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (observation without treatment)
Trial: 30357823
Drug: COSF 20
RxNorm normalized name: Cosfroviximab
DrugBank: Cosfroviximab (DB17774)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COSF 20 mg
Trial: 30357823
Drug: CTAB 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CTAB 20 mg
Trial: 30357823
Drug: COSF 10
RxNorm normalized name: Cosfroviximab
DrugBank: Cosfroviximab (DB17774)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COSF 10 mg
Trial: 30357823
Drug: CTAB 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CTAB 10 mg
Trial: 30357823
Drug: COSF 20
RxNorm normalized name: Cosfroviximab
DrugBank: Cosfroviximab (DB17774)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COSF 20 mg and COSF 10 mg
Trial: 27387994
Drug: Higher-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose edoxaban regimen (HDER) 60/30 mg
Trial: 27387994
Drug: Warfarin (INR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (INR 2.0-3.0)
Trial: 20839238
Drug: Dextromethorphan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan plus ultra low-dose quinidine (DMq) at 30/10mg (DMq-30)
Trial: 20839238
Drug: Dextromethorphan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan plus ultra low-dose quinidine (DMq) at 20/10mg (DMq-20)
Trial: 18053310
Drug: 300 mg/d
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/d of dietary secoisolariciresinol diglucoside (SDG) from flaxseed extract
Trial: 18053310
Drug: 600 mg/d
RxNorm normalized name: Rebetron, single dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg/d of dietary secoisolariciresinol diglucoside (SDG) from flaxseed extract
Trial: 12723748
Drug: Ibuprofen and
RxNorm normalized name: Ibuprofen and Famotidine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen and Paracetamol
Trial: 8740787
Drug: CMFp (Cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMFp (Cyclophosphamide, Methotrexate, 5-Fluorouracil + low-dose prednisone)
Trial: 1833897
Drug: Enoximone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (2 x bolus 0.5 mg/kg, infusion 5.0 mcg/kg/min)
Trial: 1833897
Drug: Dopamine (3-4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (3-4.0 mcg/kg/min)
Trial: 6884167
Drug: lactulose (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lactulose (40 g)
Trial: 6884167
Drug: metoclopramide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide (20 mg tds)
Trial: 6884167
Drug: magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: magnesium sulfate (0.1 g/kg body weight)
Trial: 27461523
Drug: Heat-stabilized rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat-stabilized rice bran (30 g/day)
Trial: 27461523
Drug: Cooked navy
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked navy bean powder (35 g/day)
Trial: 17242078
Drug: Glycopyrrolate (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (0.01 mg/kg)
Trial: 15065643
Drug: Diet +
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet + Sibutramine 1 x 10 mg/d (n=22)
Trial: 15065643
Drug: Diet +
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet + Orlistat 3 x 120 mg/d (n=25)
Trial: 15065643
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Diet + Sibutramine + Orlistat (n=20)
Trial: 9876861
Drug: Single session
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single session treatment (SS)
Trial: 9876861
Drug: Treatment-as-needed intervention
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-needed intervention (TAN)
Trial: 7994783
Drug: Epirubicin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (40 mg/40 ml saline) given within 24 h of TUR and once during the 1st week, weekly for 4 weeks and then monthly for 11 months
Trial: 2689017
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate cream (Dermovate) with occlusion using Comfeel Coloplast dressing
Trial: 2689017
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate cream (Dermovate) without occlusion
Trial: 27912875
Drug: Chamomile (1500mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile (1500mg, 500mg capsule 3 times daily)
Trial: 24462735
Drug: TDF +
RxNorm normalized name: Tenofovir disoproxil fumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDF + placebo (300 mg TDF)
Trial: 24462735
Drug: TDF +
RxNorm normalized name: Tenofovir disoproxil fumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDF + emtricitabine (300 mg TDF + 200 mg emtricitabine)
Trial: 21122701
Drug: 25 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g/d of an insoluble fraction of partially hydrolyzed soy protein (SP)
Trial: 21122701
Drug: 25 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g/d total milk proteins (TMP)
Trial: 16796928
Drug: Pulmonary artery
RxNorm normalized name: Pulmonary artery blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary artery perfusion with hypothermic washed red blood cell solution during CPB
Trial: 11126231
Drug: Modified cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified cognitive-behavioural treatment (M-CBT)
Trial: 11126231
Drug: Standard cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive-behavioural therapy (S-CBT)
Trial: 2062772
Drug: urapidil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: urapidil (30 mg twice daily)
Trial: 6134136
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg/day)
Trial: 20359693
Drug: Alcohol Behavioral
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol Behavioral Individual Treatment (ABIT)
Trial: 20359693
Drug: Alcohol Behavioral
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol Behavioral Couples Treatment (ABCT)
Trial: 17957149
Drug: Subcutaneous pramlintide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous pramlintide injection (5 microg/unit of insulin)
Trial: 17957149
Drug: Subcutaneous pramlintide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous pramlintide infusion (5 microg/unit of insulin over 120 min)
Trial: 17957149
Drug: Insulin-only administration
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-only administration
Trial: 17047667
Drug: Naltrexone (NTX)
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone (NTX) 50 mg
Trial: 1971034
Drug: Alteplase (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (100 mg intravenous plus heparin)
Trial: 399767
Drug: Modified activities
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified activities of daily living (ADL) index
Trial: 23433257
Drug: Chloramphenicol suspension
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol suspension (1 drop)
Trial: 23433257
Drug: Chloramphenicol gel
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol gel (1 application)
Trial: 23433257
Drug: Netilmicin suspension
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin suspension (1 drop)
Trial: 23433257
Drug: Tobramycin suspension
RxNorm normalized name: Tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin suspension (1 drop)
Trial: 23433257
Drug: Chloramphenicol suspension
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol suspension (repeated instillations every 10 min for a total of 4 drops)
Trial: 23433257
Drug: Chloramphenicol gel
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol gel (repeated instillations every 10 min for a total of 4 drops)
Trial: 16730318
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) intervention, weekly sessions over 6 weeks
Trial: 30185575
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behaviour therapy (ICBT) with therapist support
Trial: 30185575
Drug: Unguided internet-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unguided internet-based cognitive behaviour therapy (ICBT)
Trial: 30185575
Drug: Face-to-face cognitive
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-face cognitive behaviour therapy (f2f CBT)
Trial: 26961111
Drug: Total risk
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total risk management (LDL‐C <80 mg/dL, systolic BP <130 mmHg, and HbA1c <6.5%)
Trial: 24976447
Drug: Starting dose
RxNorm normalized name: Austedo 6 MG Starting Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starting dose of 7.5 mg MTX per week (group 1)
Trial: 24976447
Drug: Starting dose
RxNorm normalized name: Austedo 6 MG Starting Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starting dose of 15 mg MTX per week (group 2)
Trial: 27669162
Drug: Trauma-focused cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused cognitive behavior therapy (CBT)
Trial: 27669162
Drug: Trauma-focused cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused cognitive therapy (CT)
Trial: 18266402
Drug: Once-daily inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily inhaled SFC 50 microg/100 microg
Trial: 18266402
Drug: Twice-daily inhaled
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily inhaled FP 100 microg
Trial: 16983913
Drug: Zhiling Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhiling Capsule (ZC) - whole recipe, administered orally for 2 weeks
Trial: 16983913
Drug: Disassembled recipe
RxNorm normalized name: SALICYLIC ACID 1 g in 100 mL TOPICAL SHAMPOO [Maetria Miracle Recipe PremiumShampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disassembled recipe 1 (Western medicines) of ZC, administered orally for 2 weeks
Trial: 16983913
Drug: Disassembled recipe
RxNorm normalized name: SALICYLIC ACID 1 g in 100 mL TOPICAL SHAMPOO [Maetria Miracle Recipe PremiumShampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disassembled recipe 2 (Chinese medicines) of ZC, administered orally for 2 weeks
Trial: 16983913
Drug: Pingxiao Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pingxiao Capsule (Control), administered orally for 2 weeks
Trial: 14534336
Drug: Gentamicin (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (0.3 percent, or 3 mg per milliliter) administered topically, three times daily for 14 days
Trial: 14534336
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered topically, three times daily for 14 days
Trial: 11264156
Drug: GM-CSF priming
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GM-CSF priming (250 microg/m(2) twice daily for 5 days before treatment)
Trial: 9247942
Drug: 0.075 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg/kg midazolam